Decreased levels of serum soluble HLA class I antigens in HLA-B27 positive spondyloarthropathies

Annals of the Rheumatic Diseases

Volumn 65, Issue 2, 2006, Pages 279-280

  Toussirot, E ^a   Saas, P ^b   Pariset, J ^b   Chabod, J ^b   Tiberghien, P ^b   Wendling, D ^a  

^a UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HLA ANTIGEN CLASS 1; HLA B27 ANTIGEN;

ADULT; ANKYLOSING SPONDYLITIS; ANTIGEN BINDING; ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXIC T LYMPHOCYTE; DISEASE ACTIVITY; DISEASE MARKER; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN LOCALIZATION; SPONDYLOARTHROPATHY; SYNOVIAL FLUID;

ADULT; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-B27 ANTIGEN; HUMANS; MALE; SPONDYLITIS, ANKYLOSING;

EID: 31144435955     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2005.037986     Document Type: Article

References (10)

1. Puppo F, Scudeletti M, Indiveri F, Ferrone S. Serum HLA class I antigens: markers and modulators of an immune response? Immunol Today 1995;16:124-7.
2. Puppo F, Indiveri F, Scudeletti M, Ferrone S. Soluble HLA antigens: new roles and uses. Immunol Today 1997;18:154-5.
3. Migliaresi S, Bresciani A, Ambrosone L, Spera M, Barbarulo D, Lombari V, et al. Increased serum concentrations of soluble HLA-class I antigens in hepatitis C virus related mixed cryoglobulinemia. Ann Rheum Dis 2000;59:20-5.
4. Tsuchiya N, Shiota M, Yamaguchi A, Ito K. Elevated serum level of soluble HLA class I antigens in patients with systemic lupus erythematosus. Arthritis Rheum 1996;39:792-6.
5. Wolf RE, Adamashvili IM, Gelder FB, Hall VC, Fraser PA, McDonald JC. Soluble HLA-I in rheumatic diseases. Hum Immunol 1998;59:644-9.
6. Adamashvili IM, McDonald JC, Fraser PA, Milford EL, Pressly TA, Gelder FB. Soluble HLA class I antigens in patients with rheumatoid arthritis and their families. J Rheumatol 1995;22:1025-31.
7. Dougados M, Van der Linden S, Juhlin R, Huilfeldt B, Amor B, Calin A, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991;34:1218-27.
8. Aultman D, Adamashvili I, Yaturu K, Langford M, Gelder F, Gautreaux M, et al. Soluble HLA in human body fluids. Hum Immunol 1999;60:239-44.
9. Munoz-Fernandez S, Martin J, Martin-Mola E, Garcia-Rodriguez MC, Cantalejo M, Fontan G, et al. Soluble HLA class I antigens in serum and synovial fluid from patients with rheumatoid arthritis and other arthropathies. Rheumatology (Oxford). 2001;40:1365-9).
10. Allen RL, O'Callaghan CA, McMichael AJ, Bowness P. Cutting edge: HLA-B27 can form a novel β2-microglobulin-free heavy chain homodimer structure. J Immunol 1999;162:5045-8.